Current project: Functional interaction of VPS35 and α-synuclein in models of Parkinson’s disease.
Education: B.Sc. (Hon) in anatomy and human cell biology, University of Liverpool, UK (2010)
M.Res. in biomedical sciences, University of Liverpool, UK (2011)
Ph.D. in cellular and molecular physiology, University of Liverpool, UK (2014)
Current project: Genetic modifiers and cellular pathways of LRRK2-induced toxicity in Parkinson’s disease
Education: B.S. in biology, Northern Arizona University, Arizona (2012)
Current project: Defining LRRK2 substrates/interactors and pathways of neurotoxicity
Education: Shahjalal University of Science and Technology, Bangladesh (B.S. in physics);
Shahjalal University of Science and Technology, Bangladesh (M.S. in physics);
University of Twente, The Netherlands (M.S. in applied physics (optics and biophysics); Silantes GmbH and Max Planck Institute for Heart and Lung Research, Germany (Ph.D. in biochemistry)
Current project: Identification of proteins that regulate LRRK2 GTPase activity and cellular toxicity.
Education: B.S. in biology/B.A. in psychology, University of Cincinnati, Ohio (1994)
M.S. in biology, University of Cincinnati, Ohio (1996)
Current project: Mechanisms of LRRK2-dependent neurotoxicity in models of Parkinson’s disease
Education: B.S., University of Illinois, Chicago (1995)
Current project: Contribution of LRRK2 enzymatic activity in rodent models of Parkinson’s disease.
Education: B.S. in life science, cell biology and biochemistry, Angers University, France (2007)
M.S. in life science, cell signaling and physiopathology, Angers University, France (2009)
Ph.D. in neuroscience, University of Tübingen, Germany (2015)
Current project: Exploring the VPS35 protein interactome in Parkinson’s disease.
Education: B.A. in biology, Anderson University, Indiana (2013)
Current project: Contribution of the Roc-COR domain to LRRK2 activity and neurotoxicity.
Education: B.S. in cell and molecular biology, Grand Valley State University, Michigan (2015)